pamidronate has been researched along with vitamin d 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mautalen, C; Pérez Lloret, A; Roldán, EJ; Vega, E | 1 |
| Demura, H; Imaki, T; Kasajima, T; Kobayashi, T; Sato, K; Takeuchi, A; Tanaka, M; Toraya, S | 1 |
| Chapurlat, R; Meunier, PJ | 1 |
| Brown, E; Butters, R; Egbuna, O; Goltzman, D; Kantham, L; Pang, J; Pollak, M; Quinn, S | 1 |
1 review(s) available for pamidronate and vitamin d 2
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pamidronate and vitamin d 2
| Article | Year |
|---|---|
Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
Topics: Aged; Alkaline Phosphatase; Body Temperature; Bone and Bones; Calcium; Diphosphonates; Ergocalciferols; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Tablets, Enteric-Coated | 1994 |
5 other study(ies) available for pamidronate and vitamin d 2
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Increased 1,25-(OH)2D2 concentration in a patient with malignancy-associated hypercalcemia receiving intravenous hyperalimentation inadvertently supplemented with vitamin D2.
Topics: Calcitriol; Contraindications; Diphosphonates; Ergocalciferols; Humans; Hypercalcemia; Male; Middle Aged; Neoplasm Proteins; Pamidronate; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parenteral Nutrition, Total; Protein Biosynthesis; Stomach Neoplasms | 1993 |
The nonsurgical treatment of fibrous dysplasia.
Topics: Adolescent; Bone Density; Calcium; Diphosphonates; Ergocalciferols; Female; Fibrous Dysplasia of Bone; Follow-Up Studies; Fractures, Spontaneous; Humans; Pain; Pamidronate; Radiography | 1999 |
The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone.
Topics: Animals; Calcitonin; Calcium; Calcium, Dietary; Creatinine; Diphosphonates; Duodenum; Ergocalciferols; Gene Expression Regulation; Genotype; Injections, Intraperitoneal; Intestinal Absorption; Kidney; Mice; Mice, Knockout; Pamidronate; Parathyroid Hormone; Phenotype; Receptors, Calcium-Sensing | 2009 |